Neurocarrus Inc

Targeted pain relief without addiction.

Monterey, United States · Founded 2017 · $354K raised

Employees
1–10
Founded
2017
Total Funding
$354K
Last Round
$344K SAFEApr 2019
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Neurocarrus is a pre-clinical biotechnology company developing targeted protein therapeutics for pain management and neurological disorders without addiction risk. Its Apollo drug delivery platform engineers proteins to target and deliver therapeutics directly to selected tissues and cells. Lead assets include N-001 for acute surgical pain, NL-17 for migraine prevention, and N-19a for chronic pain — all designed to provide lasting relief without opioid-associated side effects. The company is backed by NIH SBIR grants and has partnered with Stanford University and the VA Palo Alto Medical Center.

Summary

Neurocarrus Inc is a Biotech company based in Monterey, United States, founded in 2017. It has raised $354K in total across 3 rounds, most recently a $344K SAFE round in Apr 2019. Investors include SOSV and National Institute on Drug Abuse.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SAFEApr 2019
$344K

Sign up to see all 3 events

Funding: Seed through SAFE. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurocarrus Inc on Indexed.vc
<a href="https://indexed.vc/companies/neurocarrus-inc"><img src="https://indexed.vc/api/badge/company/neurocarrus-inc" alt="Neurocarrus Inc on Indexed.vc" width="260" height="76" /></a>